Literature DB >> 1920488

Antiestrogen resistance: mechanisms by which breast cancer cells undermine the effectiveness of endocrine therapy.

B S Katzenellenbogen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1920488     DOI: 10.1093/jnci/83.20.1434

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  12 in total

1.  A transcriptional enhancer required for the differential expression of the human estrogen receptor in breast cancers.

Authors:  Z Tang; I Treilleux; M Brown
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

2.  The Wilms' tumor suppressor WT1 induces estrogen-independent growth and anti-estrogen insensitivity in ER-positive breast cancer MCF7 cells.

Authors:  Lei Wang; Zhao-Yi Wang
Journal:  Oncol Rep       Date:  2010-04       Impact factor: 3.906

3.  Cell cycle expression of estrogen receptors determined by image analysis on human breast cancer cells in vitro and in vivo.

Authors:  P Rostagno; J L Moll; I Birtwisle-Peyrottes; F Ettore; C Caldani
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 4.  Effects of psoralens as anti-tumoral agents in breast cancer cells.

Authors:  Maria Luisa Panno; Francesca Giordano
Journal:  World J Clin Oncol       Date:  2014-08-10

5.  The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens.

Authors:  M M Montano; B S Katzenellenbogen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

6.  Mechanisms of resistance to structurally diverse antiestrogens differ under premenopausal and postmenopausal conditions: evidence from in vitro breast cancer cell models.

Authors:  Ping Fan; Wei Yue; Ji-Ping Wang; Sarah Aiyar; Yan Li; Tae-Hyun Kim; Richard J Santen
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

7.  Measurement of steroid hormone receptors in breast cancer patients on tamoxifen.

Authors:  C A Encarnación; D R Ciocca; W L McGuire; G M Clark; S A Fuqua; C K Osborne
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

8.  Modulators of cellular protein phosphorylation alter the trans-activation function of human progesterone receptor and the biological activity of progesterone antagonists.

Authors:  D P Edwards; N L Weigel; S K Nordeen; C A Beck
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

Review 9.  William L. McGuire Memorial Symposium. Estrogen receptors: ligand discrimination and antiestrogen action.

Authors:  B S Katzenellenbogen; H Fang; B A Ince; F Pakdel; J C Reese; C H Wooge; C K Wrenn
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

Review 10.  What do we know and what don't we know about tamoxifen in the human uterus.

Authors:  A Friedl; V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.